tiprankstipranks
Zymeworks: Hold Rating Amid Financial Challenges and Upcoming Catalysts
PremiumRatingsZymeworks: Hold Rating Amid Financial Challenges and Upcoming Catalysts
20d ago
Zymeworks price target raised to $13 from $12 at H.C. Wainwright
Premium
The Fly
Zymeworks price target raised to $13 from $12 at H.C. Wainwright
20d ago
Zymeworks price target raised to $19 from $18 at Citi
Premium
The Fly
Zymeworks price target raised to $19 from $18 at Citi
23d ago
Zymeworks Reports 2024 Financial Results and Pipeline Progress
PremiumCompany AnnouncementsZymeworks Reports 2024 Financial Results and Pipeline Progress
25d ago
Zymeworks Achieves FDA Approval for Ziihera®
Premium
Company Announcements
Zymeworks Achieves FDA Approval for Ziihera®
25d ago
Zymeworks reports Q 4EPS (31c), consensus (9c)
Premium
The Fly
Zymeworks reports Q 4EPS (31c), consensus (9c)
25d ago
Zymeworks Welcomes Oleg Nodelman to Board of Directors
PremiumCompany AnnouncementsZymeworks Welcomes Oleg Nodelman to Board of Directors
1M ago
Zymeworks appoints Oleg Nodelman to Board
Premium
The Fly
Zymeworks appoints Oleg Nodelman to Board
1M ago
Zymeworks to Announce 2024 Financial Results and Host Corporate Update
Premium
Company Announcements
Zymeworks to Announce 2024 Financial Results and Host Corporate Update
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100